Amresh Kumar - 06 May 2024 Form 4/A Insider Report for Acasti Pharma Inc. (GRCE)

Role
VP Program Management
Signature
/s/ Amresh Kumar
Issuer symbol
GRCE
Transactions as of
06 May 2024
Net transactions value
$0
Form type
4/A
Filing time
10 May 2024, 16:07:54 UTC
Date Of Original Report
08 May 2024
Previous filing
18 Jul 2023
Next filing
16 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +19,740 $0.000000 19,740 06 May 2024 Class A Common Shares 19,740 $2.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory.
F2 Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.